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Abstract15
Nanoparticles capable of generating controlled amounts of intracellular reactive oxygen16
species (ROS) were synthesized by functionalizing polyacrylamide nanoparticles with Zinc (II)17
porphyrin photosensitisers. Controlled ROS production was demonstrated in human18
mesenchymal stem cells (hMSCs) through 1) production of nanoparticles functionalized with19
varying percentages of Zinc (II) porphyrin and 2) modulating the number of doses of20
excitation light to internalized nanoparticles. hMSCs treated with nanoparticles21
functionalized with increasing percentages of Zn(II) porphyrin and high number of22
irradiations of excitation light were found to generate greater amounts of ROS. A novel dye,23
which is transformed into a fluorescent entity in the presence of hydrogen peroxide,24
provided an indirect indicator for cumulative ROS production. The mitochondrial membrane25
potential was monitored to investigate the destructive effect of increased intracellular ROS26
production. Flow cytometric analysis of nanoparticle treated hMSCs suggested irradiation27
with excitation light signalled controlled apoptotic cell death, rather than uncontrolled28
necrotic cell death. Increased intracellular ROS production did not induce phenotypic29
changes in hMSC subcultures. Zn (II) porphyrin functionalised nanoparticles could find broad30
utility in stimulation of intracellular oxidative stress and communication.3132
Introduction33
Reactive oxygen species (ROS) form through conversion of molecular oxygen, by either (Type34
I) electron transfer, to produce superoxide, hydrogen peroxide (H2O2) and hydroxyl radicals35
or, (Type II) energy transfer, to produce singlet oxygen.1 At a cellular level ROS production is36
highly regulated, typically through confinement of their production to specific organelles,37
such as the mitochondria,2 and management of overproduction with antioxidants.338
Controlled ROS production is known to regulate processes, such as programmed cell death,439
initiation of host defences to pathogens5 and production of energy via the mitochondrial40
electron transport chain.6 Uncontrolled ROS production can propagate chain reactions that41
can cause irreversible damage to intracellular nucleic acids,7 proteins8 and lipids9 that can42
result in cellular necrosis,10 neoplastic mutations11 and neurodegenerative disorders.1243
The effects of ROS on intracellular processes have been investigated through exogenous44
addition of H2O2.13, 14 However, diffusion of H2O2 through cell membranes is thought to be45
restricted,15 due to tightly regulated membrane channels, such that the effect of exogenous46
ROS on intracellular effects can be misinterpreted.16 Therefore, artificially stimulating47
intracellular ROS, independent of innate and exogenous ROS, in a controlled manner would48
enhance the understanding of how oxidative stress contributes to healthy or diseased49
states.50
Page 2 of 14
Polyacrylamide nanoparticles are at the forefront of investigating cellular51
microenvironments of interest.17 Due to their 1) small size, 2) optical transparency, 3) large52
surface to volume ratio, and 4) highly versatile matrix, which can be readily engineered to53
control physicochemical parameters, they can be delivered to biological systems with54
minimal perturbation.18 We and others have shown previously how polyacrylamide55
nanoparticles can be utilized as an analytical tool19-22 to target subcellular spaces23-25 and56
provide a real-time measurements of the role of key biological parameters in situ.2657
More recently, polyacrylamide nanoparticles have been used as a drug delivery tool for58
photodynamic therapy27 that utilise photoexcitable compounds that cause extensive tissue59
damage when irradiated with excitation light. The damage is inflicted through the60
generation of ROS, when excited photosensitizers come into contact with biological systems.61
Porphyrins are examples of photosensitisers that have been extensively used to treat62
diseased tissue.28 They are composed of a sixteen membered aromatic ring, synthesised63
through condensation of substituted pyrroles, to produce a planar structure. The planar64
structure can be used to stabilise metal complexes, usually with a 2+ valency, which dictate65
the photo excitable properties of the porphyrin. 2966
This article describes the synthesis and characterization of polyacrylamide nanoparticles67
conjugated to Zinc (II) or Copper (II) complexed porphyrins. Nanoparticles were doped with68
cationic chemical groups, to improve sub-cellular localization30 and delivered to human69
mesenchymal stem cells (hMSCs). Control over ROS generation was demonstrated by: (1)70
attenuating the percentage of porphyrins on the nanoparticle surface and (2) modulating71
the number of light doses to the internalized nanoparticles. The degree of ROS production72
was visualized through use of a newly synthesized dye, which is chemically transformed into73
a fluorescent entity in the presence of ROS. The cytotoxic effects and possible phenotypic74
changes, induced by intracellular ROS generation, on hMSCs were investigated using flow75
cytometry.7677
Results and Discussion7879
Synthesis and Characterisation of Porphyrin Functionalised Nanoparticles8081
Two porphyrins with different metal complexes, Zn (II) and Cu (II), were utilised as part of82
this study, Scheme 1.31 Porphyrins with Zn (II) have been shown to generate ROS, whereas,83
porphyrins with Cu (II) do not demonstrate ROS production.32 The difference in activity is84
due to the electronic properties of the metal ions. When excited, porphyrins with Zn (II)85
permit intersystem crossing of electrons to the triplet state and demonstrate86
photosensitising activity. Porphyrins with Cu (II) do not permit intersystem crossing of87
excited electrons and as a result do not possess enough energy to produce photosensitising88
activity. Due to the differences in activity the Cu (II) porphyrin functionalised nanoparticles89
were utilised as a control, so that the photosensitising activity could be attributed to the Zn90
(II) porphyrin functionalised nanoparticles alone.9192
Porphyrins were covalently linked to nanoparticles via a Cu (I)-catalysed alkyne-azide93
cycloaddition reaction.31 The percentage of nanoparticle functionalization was determined94
by titrating alkyne functionalised nanoparticles with porphyrin azides. Nanoparticles95
saturated with porphyrin were considered to be 100 % functionalised. Nanoparticles96
functionalised with 5 %, 10 % and 20 % Zn(II) or Cu (II) porphyrins were prepared with97
nanoparticle diameters centred at 80 nm (ranging between 10 and 100 nm) and positive98
surface charge (zeta potential > +15 mV) (see supporting information Figure S2 and S3).99
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100
Delivery of Porphyrin Functionalised Nanoparticles101102
Mitochondria are known as the major source of ROS within cells. Therefore, it is highly103
desirable for tools engineered to trigger the production of ROS, like the porphyrin104
functionalised nanoparticles presented here, to preferentially target the mitochondria. To105
determine the subcellular localisation of the nanoparticles, co-localisation analyses were106
performed on hMSCs treated with Zn (II) porphyrin (5%) functionalised nanoparticles, and107
stained with LysoTracker® blue and MitoTracker® Green.108109
Figure 1A shows a representative merged channel image of Zn (II) porphyrin functionalised110
nanoparticles delivered to hMSCs. The insets show the individual channels; (Ai) brightfield,111
(Aii) blue (LysoTracker®), (Aiii) green (MitoTracker®) and (Aiv) red fluorescent channels (Zn112
(II) porphyrin conjugated nanoparticles). Separation of the fluorescence channels to observe113
co-localisation of Zn (II) porphyrin functionalised nanoparticles with the mitochondria,114
Figure 1B, and lysozymes, Figure 1C, facilitates characterisation of the subcellular location.115116
The lysozymes, as highlighted by LysoTracker® blue, appear in punctate vesicles that are co-117
localised in regions with Zn (II) porphyrin functionalised particles (Figure 1B, purple). The118
nanoparticles are internalized efficiently as highlighted by the strong signal observed in the119
red fluorescence channel (Figure 1Aiv). The mitochondria, identified by MitoTracker® green,120
are distributed throughout the cytoplasm and are also co-localised with Zn (II) porphyrin121
conjugated nanoparticles (Figure 1C). The images comprising Figure 1 indicate porphyrin122
functionalised nanoparticles are internalised and preferentially associate with mitochondria,123
although not exclusively, over lysozymes.124125
Fluorescence Imaging ROS Production126127
A novel dye, 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)-2H-128
chromen-2-one (BPTFMC), was used to deterimine the ability of the Zn(II) porphyrin129
functionalised nanoparticles to generate ROS. BPTFMC is transformed in the presence of130
hydrogen peroxide (H2O2) to the fluorescent entity 7-hydroxy-4-(trifluoromethyl)-2H-131
chromen-2-one (HTFMC), Scheme 2. Visulisation of HTFMC fluorescence in subcellular132
spaces can therefore be utilised as an indirect indicator for cumulative ROS production (see133
supporting information Figures S6-S8).134135
Controlled ROS generation in hMSCs136137
Controlled ROS production in hMSCs was demonstrated through: 1) irradiation of138
internalised nanoparticles with increasing percentages of Zn (II) porphyrin (5 %, 10 % and 20139
%), with a single dose of excitation light and 2) irradiation of internalised nanoparticles,140
functionalised with 5% Zn(II) porphyrin, with repeated doses of excitation light.141142143
Effect of increases in the percentage of Zn (II) porphyrin functionalisation144145
The effect of a single dose of excitation light on internalised nanoparticles bearing 5 %, 10 %146
and 20 % of Zn(II) porphyrin was investigated. hMSCs were treated with nanoparticle147
suspensions after which they were thoroughly washed to remove non-internalised148
nanoparticles then stained with BPTFMC and MitoTracker® red; to observe ROS production149
events and location of viable mitochondria in sub-cellular spaces, respectively.150
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ĨƚĞƌŝƌƌĂĚŝĂƚŝŽŶǁŝƚŚĂƐŝŶŐůĞĚŽƐĞŽĨůŝŐŚƚ;ϱϭϮʅt͕ϴŵŵ2, 2 seconds), an increase in the152
fluorescence intensity from HTMFC (blue) was observed, which correlates with percentage153
increases in Zn (II) porphyrin conjugated to the nanoparticle, Figure 2. The extent of154
cytotoxicity caused by the ROS production was demonstrated by the fluorescence response155
from MitoTracker® red, which emits a fluorescence response when bound to viable156
mitochondrial membranes with active membrane potentials.33 Figure 2 highlights the157
presence of a ‘blast zone’ within which substantial amounts ROS has been produced, whilst158
the number of cells with active mitochondrial membrane potentials has been considerably159
reduced. The extent of the lethality of high percentages of Zn (II) porphyrin is demonstrated160
by hMSCs treated with 20 % Zn(II) porphyrin, which show a clear perimeter between viable161
and non-viable cells. Therefore, the extent of ROS production and consequential162
cytotoxicity, as indicated by enhanced HTFMC and diminished MitoTraker® red fluorescence,163
respectively, is profoundly influenced by increases in the percentage of porphyrin164
functionalization.165166
Effect of repeat doses of excitation light to produce ROS167168
A single dose of excitation light produced subtle increases in ROS for hMSCs treated with169
nanoparticles functionalised with 5% Zn (II) porphyrin, Figure 2. To investigate if ROS170
production can be augmented in a controlled manner, internalised nanoparticles171
functionalised with 5% Zn (II) porphyrin were subjected to repeat doses of excitation light.172
hMSCs were irradiated with a dose of excitation light every 5 minutes for 100 minutes. The173
progress of cellular events was captured at 5, 30, 60 and 100 minutes, corresponding to 1, 6,174
12 and 20 irradiations, respectively, Figure 3.175176
hMSCs treated with 5% Cu(II) functionalised porphyrins show no observable differences in177
cellular morphology, increases in ROS production or cytotoxicity after 20 irradiations, as178
indicated by brightfield images, absence of HTFMC fluorescence and similarity of179
fluorescence emission from mitrotracker red across all time points, respectively. This180
observation is also true for hMSCs treated with nanoparticles functionalised with 5% Zn(II)181
porphyrin after a single dose of excitation light.182183
The first signs of ROS generation appear after 6 irradiations for hMSCs treated with 5% Zn(II)184
functionalised nanoparticles, Figure 3 (blue). At these low levels of ROS, there are no185
apparent changes in cellular toxicity, as there are no noticeable changes in cellular186
morphology or fluorescence intensity from MitoTracker® red. After 12 irradiations, ROS187
production and its cytotoxic effects are evident, as the fluorescence intensity of HTFMC is188
pronounced; the signal from the MitoTracker® red begins to decrease and the first signs of189
apoptotic blebbling can also be observed on cell surfaces (Figure 3). For hMSCs dosed with190
20 irradiations of excitation light the signal from HTMFC was intensified further, suggesting191
sub-cellular spaces were being enriched with ROS. In addition, the MitoTracker® red192
emission was greatly diminished, implying that the number of active mitochondrial193
membrane potentials was reduced; and there are more signs of a decline in cellular viability194
as bright field images showed signs of increases in apoptotic blebbing (Figure 3).195196197198
Quantification of the effects of controlled intracellular ROS generation on cellular viability199
and hMSCs characterisation200201
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Flow cytometry was employed to quantify the viability and any phenotypic variation in hMSC202
populations treated with Zn (II) porphyrin functionalised nanoparticles and after203
illumination with repeated doses of light (produced using a custom designed irradiator that204
replicated the power and wavelength of excitation light used during fluorescence205
microscopy, see supporting information). Cell viability, apoptosis (controlled cell death),206
necrosis (uncontrolled cell death), and cellular differentiation were investigated through the207
use of fluorescent probes. Apoptosis was investigated using Annexin V Alexa Flour® 488,208
which binds to cell surface markers that are translocated during apoptosis.35 Whereas,209
necrosis was determined using the DNA intercalator propidium iodide, which stains210
deteriorating cells with permeable membranes.36 The effect of intracellular ROS on hMSCs211
phenotype was studied using fluorescent antibodies for specific cell surface markers.37, 38212213
Controlled apoptotic and uncontrolled necrotic cell death214215
Figure 4 shows there are no significant differences in the percentage of apoptotic and216
necrotic cells for 1) untreated and 2) Cu (II) porphyrin functionalised nanoparticle treated217
hMSC populations, after irradiation with 5 to 20 doses of excitation light (approximately 20%218
of the population express markers for apoptotic events that can be attributed to cell death219
during storage and thawing). However, hMSCs treated with Zn (II) porphyrin functionalised220
particles demonstrate statistically significant increases in the population of apoptotic cells221
when compared to 1) untreated and Cu(II) functionalised nanoparticle treated hMSCs222
(p<0.05) and 2) after repeated irradiation with excitation light (p<0.001). Dosing hMSCs with223
5, 10, 15 and 20 irradiations of excitation light increases the percentage of apoptotic cells to224
29 %, 30 %, 37 % and 44 %, respectively (n=6). We postulate that the percentage of225
apoptotic cells does not increase at low irradiation levels due to the natural antioxidant226
levels present in the cell.34 However, once this antioxidant reservoir is exhausted it is227
noticeable the percentage of apoptotic cells increases linearly with light irradiations.228229
Populations of untreated hMSCs and Cu (II) or Zn (II) porphyrin functionalised nanoparticles230
treated hMSCs contained low levels of propidium iodine positive cells; less than 5% of total231
population, Figure 4. There were no significant differences between the hMSC populations232
after repeated doses of excitation light, from 5 to 20 irradiations. These findings suggest233
repeated irradiation of internalised Zn (II) porphyrin functionalised nanoparticles generate234
doses of ROS that signal hMSCs to undergo controlled apoptotic cell death rather than235
uncontrolled necrotic cell death. These observations also mirror findings observed in Figure236
3, which show signs of apoptotic blebbing, rather than necrotic cell lysis.237238
hMSC differentiation239240
Phenotypic characterisation of hMSCs was explored, by fluorescently labelling cell surface241
markers with antibodies, after 20 irradiations of excitation light and two cellular passages.242
Phenotypic characterisation of hMSCs showed untreated hMSCs and, Cu (II) or Zn (II)243
porphyrin functionalised nanoparticle treated hMSCs presented virtually identical244
phenotypic profiles (see supporting information Figure S9 & S10). These results suggest that245
irradiation of Zn (II) porphyrin functionalised nanoparticles and subsequent ROS generation246
does not change the phenotype or induce senescence patterns in hMSCs.247248249
Conclusion250251
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We have demonstrated nanoparticles functionalised with Zn (II) porphyrin trigger252
intracellular ROS production. The intracellular effects of enhanced ROS production were253
evidenced through visualisation using BPTFMC, which is transformed into fluorescent254
HTMFC in the presence of H2O2, and observation of diminishing mitochondrial membrane255
potentials, using MitoTracker® red. Increases in: 1) the percentage of Zn (II) porphyrin256
conjugated to nanoparticles, from 5 % to 20 %, and 2) the number of irradiations of257
excitation light, enhanced ROS production and subsequent cytotoxicity. Controlled258
irradiation of Zn (II) porphyrin functionalised nanoparticles was found to signal apoptosis in259
hMSCs, but did not induce necrosis or phenotypic changes in hMSC subcultures. We260
anticipate porphyrin functionalised nanoparticles will prove to be a valuable tool to generate261
controlled amounts of intracellular ROS to advance the study of cellular processes and262
disease progression.263264
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389390
Scheme 1. Chemical structure of azide functionalised cationic porphyrin with zinc (II) and391
copper (II) metal centres.392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424
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425426
Figure 1. (A) Merged fluorescence image of (Ai) bright-field image of hMSCs treated with427
(Aii) LysoTracker® blue, (Aiii) MitoTracker®green and (Aiv) Zn(II) porphyrin conjugated428
nanoparticles (red). Co-localisation analysis between (B) Zn(II) porphyrin conjugated429
nanoparticles and LysoTracker® blue, and (C) Zn(II) porphyrin conjugated nanoparticles and430
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461
Scheme 1. Reaction between non-fluorescent 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-462
yl)-4-(trifluoromethyl)-2H-chromen-2-one (BPTFMC) and ROS producing fluorescent -463
hydroxy-4-(trifluoromethyl)-2H-chromen-2-one (HTFMC). HTFMC peak excitation and464
emmsion wavelengths are 395 nm and 435 nm, respectively.465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496
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497498
Figure 2. Bright-field and fluorescence images of untreated hMSCs and hMSCs treated with499
5, 10 and 20 % Zn(II) functionalised nanoparticles, stained with BPTFMC and MitoTracker500
Red, irradiated with a single dose of light. BPTFMC, in the presence of H2O2, is converted to501
ĨůƵŽƌĞƐĐĞŶƚ,dD&͘^ĐĂůĞďĂƌсϱϬʅŵ͘502503504505506507508
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Figure 3. (1) Merged bright-field and fluorescence images of hMSCs with internalised Cu(II)513
(control) and Zn(II) functionalised nanoparticles (photosensitiser) and (2) merged514
fluorescence images of hMSCs stained with BPTFMC and MitoTracker® red. Green, blue and515
red fluorescence are indicative of (1) nanoparticle location, (2) HTFMC production and516
subsequent ROS production and (3) active mitochondrial membrane potentials and cell517
ǀŝĂďŝůŝƚǇ͘^ĐĂůĞďĂƌсϮϬʅŵ͘518519520521
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Figure 4. Comparison of untreated (blue) and 5% Cu (II) (green) or 5% Zn (II) (red)526
functionalised nanoparticle treated hMSC populations undergoing apoptosis (Ap, solid) and527
necrosis (Nec, diagonal lines) after 5, 10, 15 and 20 irradiations of excitation light.528
Percentage of apoptosis and necrosis was determined using flow cytometry by staining529
apoptotic hMSCs with Annexin V 488 and propidium iodide, respectively. Error bars530
represent standard deviation from the mean (n=6). One Way ANOVA *** = p < 0.001; One531
way ANOVA * = p < 0.05. P values less than 0.05 were considered statistically different.532533
